These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28364690)

  • 1. Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants.
    Prandoni P; Ageno W; Mumoli N; Zanatta N; Imberti D; Visonà A; Ciammaichella M; Simioni L; Cappelli R; Bucherini E; Di Nisio M; Avruscio G; Camporese G; Parisi R; Cuppini S; Turatti G; Noventa F; Sarolo L
    Thromb Res; 2017 May; 153():97-100. PubMed ID: 28364690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of residual thrombosis on the long-term outcome of patients with deep venous thrombosis treated with conventional anticoagulation.
    Prandoni P; Lensing AW; Prins MH; Pesavento R; Piccioli A; Sartori MT; Tormene D; Milan M; Vedovetto V; Noventa F; Villalta S; Harenberg J
    Semin Thromb Hemost; 2015 Mar; 41(2):133-40. PubMed ID: 25682083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.
    Prandoni P; Ageno W; Ciammaichella M; Mumoli N; Zanatta N; Imberti D; Visonà A; Bucherini E; Di Nisio M; Noventa F;
    Intern Emerg Med; 2020 Apr; 15(3):447-452. PubMed ID: 31667697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S; Malato A; Saccullo G; Iorio A; Di Ianni M; Caracciolo C; Coco LL; Raso S; Santoro M; Guarneri FP; Tuttolomondo A; Pinto A; Pepe I; Casuccio A; Abbadessa V; Licata G; Battista Rini G; Mariani G; Di Fede G
    Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
    Ferreira T; Huber SC; de Moraes Martinelli B; Junior AL; Menezes FH; Orsi FA; Bittar LF; de Oliveira LFG; Sodre LR; Mello TT; Rielli G; Colella MP; de Paula EV; Yamaguti-Hayakawa GG; Montalvão S; Annichino-Bizzacchi JM
    Vascul Pharmacol; 2020 Jan; 124():106608. PubMed ID: 31678199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
    Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
    Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in Deep Venous Thrombosis: Current Trends in the Era of Non- Vitamin K Antagonists Oral Anticoagulants.
    Papakonstantinou PE; Tsioufis C; Konstantinidis D; Iliakis P; Leontsinis I; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2692-2702. PubMed ID: 32310041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of isolated distal deep-vein thrombosis with direct oral anticoagulants in the RIETE registry.
    Galanaud JP; Trujillo-Santos J; Bikdeli B; Di Micco P; Bortoluzzi C; Bertoletti L; Pedrajas JM; Ballaz A; Alfonso J; Monreal M;
    J Thromb Thrombolysis; 2021 Aug; 52(2):532-541. PubMed ID: 33247808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.
    Prandoni P; Lensing AW; Prins MH; Bernardi E; Marchiori A; Bagatella P; Frulla M; Mosena L; Tormene D; Piccioli A; Simioni P; Girolami A
    Ann Intern Med; 2002 Dec; 137(12):955-60. PubMed ID: 12484710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.
    Prandoni P; Prins MH; Lensing AW; Ghirarduzzi A; Ageno W; Imberti D; Scannapieco G; Ambrosio GB; Pesavento R; Cuppini S; Quintavalla R; Agnelli G;
    Ann Intern Med; 2009 May; 150(9):577-85. PubMed ID: 19414836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study.
    Martinez C; Katholing A; Folkerts K; Rietbrock S
    Curr Med Res Opin; 2018 Nov; 34(11):1985-1990. PubMed ID: 29798688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Direct Oral Anticoagulants in Patients with Splanchnic Vein Thrombosis: A Systematic Reviews and Meta-Analysis.
    Wan Y; Guo L; Xiong M
    Clin Appl Thromb Hemost; 2024; 30():10760296241274750. PubMed ID: 39135448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing clinical outcomes of vitamin K antagonists vs non-vitamin K antagonists in anticoagulant therapy for mesenteric venous thrombosis.
    Kim YH; Kim HJ; Park S; Hwang D; Kim HK; Huh S; Yun WS
    J Vasc Surg Venous Lymphat Disord; 2024 Sep; 12(5):101903. PubMed ID: 38754777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-thrombotic syndrome in patients treated with rivaroxaban or enoxaparin/vitamin K antagonists for acute deep-vein thrombosis. A post-hoc analysis.
    Cheung YW; Middeldorp S; Prins MH; Pap AF; Lensing AW; Ten Cate-Hoek AJ; Villalta S; Milan M; Beyer-Westendorf J; Verhamme P; Bauersachs RM; Prandoni P;
    Thromb Haemost; 2016 Sep; 116(4):733-8. PubMed ID: 27583311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
    J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
    Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
    Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants.
    Spiezia L; Campello E; Simion C; Poretto A; Dalla Valle F; Simioni P
    Angiology; 2022 Aug; 73(7):649-654. PubMed ID: 34989625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.
    Daher J; Da Costa A; Hilaire C; Ferreira T; Pierrard R; Guichard JB; Romeyer C; Isaaz K
    Clin Drug Investig; 2020 Apr; 40(4):343-353. PubMed ID: 32144651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.